|Conditional recommendation based on very-low-quality evidence; switching to an IL-12/23i biologic is not considered since recent trials in axial SpA were stopped.| |
|4. Switch to an IL-17i biologic over switching to an IL-12/23i (PICO 47)|Very low|
|Conditional recommendation based on very-low-quality evidence; switching to an IL-12/23i biologic is not considered since recent trials in axial SpA were stopped.| |